ROSELINE TUOPAEH: Open Payments
NPI 1558033092 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 32 payments from 20 companies in 2025. Trend: 2023 $1,286 · 2024 $1,108 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $137 |
| ABBVIE INC. | 3 | $65 |
| PFIZER INC. | 3 | $59 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Incyte Corporation | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Genentech USA, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Celgene Corporation | 1 | $28 |
Products named: RYBREVANT, DATROWAY, Enhertu, Tecentriq, IBRANCE, EPKINLY, ICLUSIG, WELIREG.
Industry payments across GA — which companies pay providers there.
